Annovis Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.

About ANVS

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs aiming to treat neurodegenerative diseases, such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. 

CEO
Maria-Luisa Maccecchini
CEOMaria-Luisa Maccecchini
Employees
8
Employees8
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2008
Founded2008
Employees
8
Employees8

ANVS Key Statistics

Market cap
66.79M
Market cap66.79M
Price-Earnings ratio
-1.82
Price-Earnings ratio-1.82
Dividend yield
Dividend yield
Average volume
378.53K
Average volume378.53K
High today
$2.73
High today$2.73
Low today
$2.50
Low today$2.50
Open price
$2.67
Open price$2.67
Volume
125.17K
Volume125.17K
52 Week high
$5.50
52 Week high$5.50
52 Week low
$1.11
52 Week low$1.11

Stock Snapshot

The current Annovis Bio(ANVS) stock price is $2.52, with a market capitalization of 66.79M. The stock trades at a price-to-earnings (P/E) ratio of -1.82.

During the trading session on 2026-03-05, Annovis Bio(ANVS) shares reached a daily high of $2.73 and a low of $2.50. At a current price of $2.52, the stock is +0.8% higher than the low and still -7.7% under the high.

Trading volume for Annovis Bio(ANVS) stock has reached 125.17K, versus its average volume of 378.53K.

Over the past 52 weeks, Annovis Bio(ANVS) stock has traded between a high of $5.50 and a low of $1.11.

Over the past 52 weeks, Annovis Bio(ANVS) stock has traded between a high of $5.50 and a low of $1.11.

People also own

Based on the portfolios of people who own ANVS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.